Department of Pharmacy, University of Rajshahi, Rajshahi 6205, Bangladesh.
Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki 569-8686, Osaka, Japan.
Int J Mol Sci. 2021 Sep 10;22(18):9807. doi: 10.3390/ijms22189807.
Macro-autophagy (autophagy) is a highly conserved eukaryotic intracellular process of self-digestion caused by lysosomes on demand, which is upregulated as a survival strategy upon exposure to various stressors, such as metabolic insults, cytotoxic drugs, and alcohol abuse. Paradoxically, autophagy dysfunction also contributes to cancer and aging. It is well known that regulating autophagy by targeting specific regulatory molecules in its machinery can modulate multiple disease processes. Therefore, autophagy represents a significant pharmacological target for drug development and therapeutic interventions in various diseases, including cancers. According to the framework of autophagy, the suppression or induction of autophagy can exert therapeutic properties through the promotion of cell death or cell survival, which are the two main events targeted by cancer therapies. Remarkably, natural products have attracted attention in the anticancer drug discovery field, because they are biologically friendly and have potential therapeutic effects. In this review, we summarize the up-to-date knowledge regarding natural products that can modulate autophagy in various cancers. These findings will provide a new position to exploit more natural compounds as potential novel anticancer drugs and will lead to a better understanding of molecular pathways by targeting the various autophagy stages of upcoming cancer therapeutics.
巨自噬(自噬)是溶酶体按需引起的高度保守的真核细胞内自我消化过程,当暴露于各种应激源(如代谢损伤、细胞毒性药物和酗酒)时,自噬会被上调作为一种生存策略。自噬功能障碍也会导致癌症和衰老,这是矛盾的。众所周知,通过靶向其机制中的特定调节分子来调节自噬,可以调节多种疾病过程。因此,自噬代表了各种疾病(包括癌症)药物开发和治疗干预的重要药理学靶点。根据自噬的框架,通过促进细胞死亡或细胞存活,自噬的抑制或诱导可以发挥治疗特性,这是癌症治疗的两个主要目标事件。值得注意的是,天然产物在抗癌药物发现领域引起了关注,因为它们具有生物友好性和潜在的治疗效果。在这篇综述中,我们总结了关于天然产物在各种癌症中调节自噬的最新知识。这些发现将为开发更多天然化合物作为潜在的新型抗癌药物提供新的思路,并通过靶向即将到来的癌症治疗的各种自噬阶段,更好地理解分子途径。